从受体生物学到治疗:不同 EGFR 突变在靶向癌症治疗开发中的重要性
From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.
66.9分
★★★☆☆
站内排序·非疗效
DISEASE HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice.
Overexpressing Bcl-2 enhances murine chimeric antigen receptor T cell therapy against solid tumor.
MEMBER ACCOUNT
登录成功会直接打开下一页。